Výsledky vyhledávání - Richard J. Battafarano
- Zobrazuji výsledky 1 - 19 z 19
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Impact of comorbidity on survival after surgical resection in patients with stage I non–small cell lung cancer Autor Richard J. Battafarano, Jay F. Piccirillo, Bryan F. Meyers, Han‐Shui Hsu, Tracey J. Guthrie, Joel D. Cooper, G. Alexander Patterson
Vydáno 2002Artigo -
11
-
12
Cost-effectiveness of routine mediastinoscopy in computed tomography– and positron emission tomography–screened patients with stage I lung cancer Autor Bryan F. Meyers, Fábio J. Haddad, Barry A. Siegel, Jennifer Bell Zoole, Richard J. Battafarano, Nirmal K. Veeramachaneni, Joel D. Cooper, G. Alexander Patterson
Vydáno 2006Artigo -
13
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer Autor Matthew J. Bott, Stephen C. Yang, Bernard J. Park, Prasad S. Adusumilli, Valerie W. Rusch, James M. Isbell, Robert J. Downey, Julie R. Brahmer, Richard J. Battafarano, Errol L. Bush, Jamie E. Chaft, Patrick M. Forde, David R. Jones, Stephen Broderick
Vydáno 2018Artigo -
14
Effects of CT Section Thickness and Reconstruction Kernel on Emphysema Quantification Autor David S. Gierada, Andrew J. Bierhals, Cliff K. Choong, Seth T. Bartel, Jon H. Ritter, Nitin A. Das, Cheng Hong, Thomas K. Pilgram, Kyongtae T. Bae, Bruce R. Whiting, Jason C. Woods, James C. Hogg, Barbara A. Lutey, Richard J. Battafarano, Joel D. Cooper, Bryan F. Meyers, G. Alexander Patterson
Vydáno 2009Artigo -
15
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses Autor Ronan J. Kelly, Blair V. Landon, Ali H. Zaidi, Dipika Singh, Jenna VanLiere Canzoniero, Archana Balan, Russell K. Hales, Khinh Ranh Voong, Richard J. Battafarano, Blair A. Jobe, Stephen C. Yang, Stephen Broderick, Jinny S. Ha, Kristen A. Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R. White, Suqi Ke, Ali Imran Amjad, Benny Weksler, Eun Ji Shin, Elizabeth D. Thompson, Kellie N. Smith, Drew M. Pardoll, Chen Hu, Josephine Feliciano, Valsamo Anagnostou, Vincent K. Lam
Vydáno 2024Artigo -
16
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) Autor Tricia R. Cottrell, Elizabeth D. Thompson, Patrick M. Forde, Julie E. Stein, Amy S. Duffield, Valsamo Anagnostou, Natasha Rekhtman, Robert A. Anders, Jonathan D. Cuda, Peter B. Illei, E Gabrielson, Frederic B. Askin, Noushin Niknafs, Kellie N. Smith, Moises J. Velez, Jennifer L. Sauter, James M. Isbell, David R. Jones, Richard J. Battafarano, Stephen C. Yang, L. Danilova, Jedd D. Wolchok, Suzanne L. Topalian, Victor E. Velculescu, Drew M. Pardoll, Julie R. Brahmer, Matthew D. Hellmann, Jamie E. Chaft, Ashley Cimino‐Mathews, Janis M. Taube
Vydáno 2018Artigo -
17
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer Autor Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith, Valsamo Anagnostou, Tricia R. Cottrell, Matthew D. Hellmann, Marianna Zahurak, Stephen C. Yang, David R. Jones, Stephen Broderick, Richard J. Battafarano, Moises J. Velez, Natasha Rekhtman, Zachary T. Olah, Jarushka Naidoo, Kristen A. Marrone, Franco Verde, Haidan Guo, Jiajia Zhang, Justina X. Caushi, Hok Yee Chan, John-William Sidhom, Robert B. Scharpf, James R. White, Edward Gabrielson, Hao Wang, Gary L. Rosner, Valerie W. Rusch, Jedd D. Wolchok, Taha Merghoub, Janis M. Taube, Victor E. Velculescu, Suzanne L. Topalian, Julie R. Brahmer, Drew M. Pardoll
Vydáno 2018Artigo -
18
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer Autor Joshua E. Reuss, Valsamo Anagnostou, Tricia R. Cottrell, Kellie N. Smith, Franco Verde, Marianna Zahurak, Mara Lanis, Joseph C. Murray, Hok Yee Chan, Caroline G. McCarthy, Daphne Wang, James R. White, Stephen C. Yang, Richard J. Battafarano, Stephen Broderick, Errol L. Bush, Malcolm V. Brock, Jinny S. Ha, David R. Jones, Taha Merghoub, Janis M. Taube, Victor E. Velculescu, Gary L. Rosner, Peter B. Illei, Drew M. Pardoll, Suzanne L. Topalian, Jarushka Naidoo, B.I. Levy, Matthew D. Hellmann, Julie R. Brahmer, Jamie E. Chaft, Patrick M. Forde
Vydáno 2020Artigo -
19
Epigenetic therapy inhibits metastases by disrupting premetastatic niches Autor Zhihao Lü, Jianling Zou, Shuang Li, Michael J. Topper, Yong Tao, Hao Zhang, Xi Jiao, Wenbing Xie, Xiangqian Kong, Michelle Vaz, Huili Li, Yi Cai, Limin Xia, Peng Huang, Kristen Rodgers, Beverly Lee, Joanne Riemer, Chi-Ping Day, Ray-Whay Chiu Yen, Ying Cui, Yujiao Wang, Yanni Wang, Weiqiang Zhang, Hariharan Easwaran, Alicia Hulbert, KiBem Kim, Rosalyn A. Juergens, Stephen C. Yang, Richard J. Battafarano, Errol L. Bush, Stephen Broderick, Stephen M. Cattaneo, Julie R. Brahmer, Charles M. Rudin, John Wrangle, Yuping Mei, Young J. Kim, Bin Zhang, Ken Kang‐Hsin Wang, Patrick M. Forde, Joseph B. Margolick, Barry D. Nelkin, Cynthia A. Zahnow, Drew M. Pardoll, Franck Housseau, Stephen B. Baylin, Lin Shen, Malcolm V. Brock
Vydáno 2020Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Cancer
Lung cancer
Surgery
Biology
Oncology
Lung
Pneumonectomy
Radiology
Paleontology
Resection
Stage (stratigraphy)
Breast cancer
Neoadjuvant therapy
Carcinoma
Genetics
Immunotherapy
Nivolumab
Survival analysis
Survival rate
Cancer registry
Cancer research
Clinical endpoint
Clinical trial
General surgery
Immunology
Ipilimumab
Mathematics
Nuclear medicine